CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 71 filers reported holding CONATUS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $5,000 | -28.6% | 16,600 | 0.0% | 0.00% | – |
| Q4 2019 | $7,000 | +40.0% | 16,600 | 0.0% | 0.00% | – |
| Q3 2019 | $5,000 | +25.0% | 16,600 | 0.0% | 0.00% | – |
| Q2 2019 | $4,000 | -90.0% | 16,600 | -55.7% | 0.00% | – |
| Q1 2019 | $40,000 | -39.4% | 37,458 | -1.8% | 0.00% | – |
| Q4 2018 | $66,000 | -70.8% | 38,152 | -2.0% | 0.00% | – |
| Q3 2018 | $226,000 | +40.4% | 38,934 | +4.0% | 0.00% | – |
| Q2 2018 | $161,000 | -93.3% | 37,444 | -90.9% | 0.00% | – |
| Q1 2018 | $2,420,000 | +30.0% | 411,838 | +2.3% | 0.00% | – |
| Q4 2017 | $1,861,000 | -8.9% | 402,414 | +8.1% | 0.00% | – |
| Q3 2017 | $2,042,000 | -2.4% | 372,111 | +2.6% | 0.00% | – |
| Q2 2017 | $2,092,000 | +460.9% | 362,811 | +690.3% | 0.00% | – |
| Q1 2014 | $373,000 | +30.4% | 45,906 | +3.6% | 0.00% | – |
| Q4 2013 | $286,000 | -24.9% | 44,293 | +16.9% | 0.00% | – |
| Q3 2013 | $381,000 | – | 37,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kalos Management, Inc. | 47,500 | $12,000 | 0.01% |
| Virtu Financial LLC | 94,842 | $25,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 467,425 | $121,000 | 0.00% |
| REILLY FINANCIAL ADVISORS, LLC | 22,011 | $6,000 | 0.00% |
| A.R.T. Advisors, LLC | 60,430 | $16,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 25,350 | $7,000 | 0.00% |
| MORGAN STANLEY | 1,019 | $0 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 24,900 | $6,000 | 0.00% |
| WOLVERINE TRADING, LLC | 30,900 | $8,000 | 0.00% |
| WOLVERINE TRADING, LLC | 26,779 | $7,000 | 0.00% |